Mts1 Activators belong to a class of chemical compounds designed to modulate the activity of metastasis suppressor protein 1 (Mts1), also known as S100A4. Mts1 is a member of the S100 family of calcium-binding proteins and plays a significant role in various cellular processes, particularly those associated with cancer metastasis. While the exact mechanisms are still under investigation, Mts1 is believed to be involved in promoting cell motility, invasion, and metastasis in cancer cells. Mts1 Activators are synthesized with the aim of selectively interacting with Mts1, influencing its cellular functions, calcium-binding properties, or interactions with other proteins, although the specific mechanisms can vary among different compounds within this chemical class.
The activation or modulation of Mts1 by these compounds can impact cancer cell behavior and metastatic potential. Mts1 has been associated with the promotion of epithelial-mesenchymal transition (EMT), a critical process in cancer metastasis where cells acquire the ability to invade surrounding tissues and migrate to distant sites in the body. Mts1 has also been linked to the regulation of cytoskeletal dynamics, cell adhesion, and signaling pathways involved in cancer progression. Mts1 Activators serve as valuable research tools for scientists studying the molecular mechanisms underlying cancer metastasis and the role of Mts1 in facilitating cancer cell dissemination. They allow researchers to investigate how Mts1-mediated processes can be modulated and contribute to metastatic spread. However, it's important to note that the specific mechanisms and outcomes of Mts1 activation may vary depending on the context and the particular compound used within this chemical class, as cancer metastasis is a multifaceted and complex process influenced by numerous factors.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, all trans, a derivative of Vitamin A, may modulate Mts1 expression by influencing cell differentiation and proliferation pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a major component of green tea, could affect Mts1 expression through its antioxidant properties and impact on cellular signaling. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane may induce Mts1 expression by impacting detoxification enzymes and oxidative stress mechanisms. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
This compound may influence Mts1 expression as part of its broad impact on cellular replication and DNA synthesis. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin could alter Mts1 expression through its effects on DNA repair mechanisms and apoptosis. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin may affect Mts1 levels through its action on DNA replication and cellular stress pathways. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate might influence Mts1 expression via pathways related to cell proliferation and immune response. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
This compound, a short-chain fatty acid, could modulate Mts1 by influencing histone modification and gene expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may impact Mts1 expression through its roles in modulating neurotransmitter pathways and cellular signaling. | ||||||